Variant report
Variant | esv2558199 |
---|---|
Chromosome Location | chr7:147726823-147728311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149846607 | chr7:147727802-147727803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533726108 | chr7:147727818-147727819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368767329 | chr7:147727825-147727826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190849017 | chr7:147727853-147727854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10952725 | chr7:147727929-147727930 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs559651460 | chr7:147727936-147727937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146858906 | chr7:147727938-147727939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140673162 | chr7:147727947-147727948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542073569 | chr7:147727951-147727952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145768374 | chr7:147727957-147727958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183932177 | chr7:147727995-147727996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541024063 | chr7:147727996-147727997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564180078 | chr7:147728000-147728001 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533235183 | chr7:147728015-147728016 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549888719 | chr7:147728043-147728044 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563650913 | chr7:147728059-147728060 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12540049 | chr7:147728115-147728116 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs10952726 | chr7:147728133-147728134 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs539446342 | chr7:147728143-147728144 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568343439 | chr7:147728145-147728146 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10952727 | chr7:147728148-147728149 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs550144506 | chr7:147728172-147728173 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146696492 | chr7:147728175-147728176 | Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571576874 | chr7:147728202-147728203 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs117290558 | chr7:147728242-147728243 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556191531 | chr7:147728244-147728245 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547102439 | chr7:147728255-147728256 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148840218 | chr7:147728264-147728265 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143469720 | chr7:147728306-147728307 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373422174 | chr7:147728311-147728312 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Heart disease | 21282601 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:147727800-147728200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:147728000-147728200 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr7:147728000-147728200 | Flanking Bivalent TSS/Enh | HUES6 Cell Line | embryonic stem cell |
4 | chr7:147728000-147728200 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
5 | chr7:147728000-147728600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr7:147728200-147729400 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |